VEGFA and neoplasm: Regarding the importance of ERO1 inhibition in counteracting tumor growth and dissemination, ERO1 genetic inhibition impairs TNBC resilience and its resistance to angiogenic and chemo-therapy, through a synergic effect in blunting VEGF secretion and impairing proteostasis [56,58].